CIPLA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > cipla

Technical Analysis

Technical Strength: 2.9 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 46.9. According to RSI analysis, cipla is marginally weak. 4.0 CIPLA RSI Chart
MACD (?) MACD: 1.13 and Signal Line: 2.27. According to MACD analysis, cipla is marginally weak. 3.0 CIPLA MACD Chart
Simple Moving Average (?) Price just got below it's 50-day simple moving average which is a negative signal. According to simple moving average analysis, cipla is facing resistance at 605 and support level is at 576.1253. 2.0 CIPLA Simple Moving Average Chart
Exponential Moving Average (?) Price just got below it's 50-day exponential moving average which is a negative signal. According to exponential moving average analysis, cipla is facing resistance at 605 and support level is at 586.2986. 2.0 CIPLA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.211. According to bollinger bands, cipla is technically weak. 3.0 CIPLA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 606.6985 and 617.525. Support level is 571.65. 2.5 CIPLA Fibonacci Retracement Chart
Average True Range (?) ATR: 13 NA CIPLA Average True Range Chart
Average Directional Index (?) ADX is 15.2 which means CIPLA is in a trading range and there is no trend. NA CIPLA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 18, 2018
Open Price 608.1
High Price 612.95
Low Price 598.25
Close Price 603.65
Absolute Change -3.5
Percentage Change -0.576%
Weekly Change -1.42%
Monthly Change 0.499%
Yearly Change 3.47%
52-week high 663.4
52-week low 480.2
Corporate Actions
ExDate Purpose
July 26, 2017 AGM/DIV-RS 2/- PER SHARE
September 12, 2016 AGM/DIV RS 2/- PER SHARE
August 11, 2015 AGM/DIV-RS 2 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.6
Confidence in Beta1.21%
Market Capital Rs. 48475.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 18.89
TTM Price-to-Earnings (P/E) Ratio 32
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 18 January 2018: Deliverable Quantity:5.32e+05 NA CIPLA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 18 January 2018: Daily Volatility:0.2159 NA CIPLA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 18 January 2018: PCR_OI:0.382 PCR:0.223 NA CIPLA PCR Chart
Option Pain (?) 18 January 2018: Max Pain:610.0 NA CIPLA Option Pain Chart
Premium (?) 18 January 2018 Premium: 0.35 Futures OI:8995000.0 NA CIPLA Premium Chart
Option_MAX_OI (?) 18 January 2018: Price:603.65 Put with maximum OI:600.0 Call with maximum OI:620.0 NA CIPLA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
January 25, 2018 604.0 8995000.0 1653.0 1735.0 603.65
February 22, 2018 606.7 350000.0 261.0 297.0 603.65
March 28, 2018 608.0 6000.0 1.0 1.0 603.65

Announcements

January 08, 2018 CiplaAnalysts/Institutional Investor Meet/Con. Call Updatesa Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
January 05, 2018 CiplaAllotment of Securitiesa Limited has informed the Exchange regarding allotment of 50413 securities pursuant to ESOP/ESPS at its meeting held on January 04, 2018
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 09, 2018 February 07, 2018 interResultsr alia to consider and approve unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2017.
October 10, 2017 November 07, 2017 interResultsr-alia to consider and approve unaudited Financial Results ( Standalone and Consolidated) for the quarter and half year ended September 30, 2017.
See all Board Meetings

CIPLA is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 582.2 Rs. 590.2 Rs. 596.9 Rs. 604.9 Rs. 611.6 Rs. 619.6 Rs. 626.3